hardy chan, ph.d.
Chairman and CEO
Dr. Hardy Wai-Hong Chan co-founded Helios Bioelectronics, Inc. in 2016. With over 40 years of experience in the Biotechnology industry, Dr. Chan enjoys translating pioneering scientific discoveries into compelling investment opportunities. Prior to founding Helios, Dr. Chan co-founded ScinoPharm Taiwan Ltd. in 1997 and served as CSO, in charge of both Research and Business Development. He then joined Tanvex Biologics, Inc. and served as CEO. Both ScinoPharm and Tanvex are listed on the Taiwanese Stock Exchange. Dr. Chan has proven himself to be a great scientist as well as a successful entrepreneur. He published over 60 scientific manuscripts in peer-reviewed journals. Dr. Chan received a Ph.D. in Biochemistry from University of Wisconsin-Madison, USA.